CMS Restructured The CAR-T Drg – What It Means For Manufacturers & 4 Strategies Forward

CMS Restructured The CAR-T DRG – What It Means For Manufacturers & 4 Strategies Forward

In the Inpatient Prospective Payment System (IPPS) Final Rule released in August 2021, the Centers for Medicare and Medicaid Services (CMS) expanded the chimeric antigen receptor T-cell (CAR-T) diagnosis-related group (DRG) to include other immunotherapies.

Read the source article at bioprocessonline.com
2021-09-17 07:26:11